Gregory Lucier - Invuity Chairman of the Board

Chairman

Mr. Gregory T. Lucier was appointed as Chairman of the Board of the Company., effective December 31, 2015. Mr. Lucier has served as a member of our board of directors since October 2014 and as the Chairman of our board of directors since December 2015. Since May 2015, Mr. Lucier has served as the Chief Executive Officer of NuVasive, a publicly traded medical device company. From November 2008 to February 2014, Mr. Lucier was Chairman of the board of directors and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. In May 2003, Mr. Lucier joined Life Technologies predecessor company, Invitrogen Corporationrationration, as Chief Executive Officer. Prior to Life Technologies, Mr. Lucier was a corporate officer at General Electric Company from 1994 to 2003 where he served in a variety of leadership roles. Mr. Lucier serves on the board of directors of NuVasive and Catalent, Inc since 2015.
Age 52
Tenure 9 years
Professional MarksMBA
Phone415-665-2100
Webhttp://www.invuity.com
Lucier received a B.S. with honors in industrial engineering from Pennsylvania State University and an M.B.A. from Harvard Business School. We believe Mr. Lucier is qualified to serve as a member of our board of directors because of his management and operational experience in the healthcare industry.

Invuity Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.4) %, meaning that it created substantial loss on money invested by shareholders. Invuity's management efficiency ratios could be used to measure how well Invuity manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 34.66 M in liabilities. Invuity has a current ratio of 2.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invuity until it has trouble settling it off, either with new capital or with free cash flow. So, Invuity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invuity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invuity to invest in growth at high rates of return. When we think about Invuity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 10 records

CHAIRMAN Age

H WoltzInsteel Industries
64
Kevin McNamaraTyson Foods
64
Daniel NovegilTernium SA ADR
67
Ronald McCrayCECO Environmental Corp
57
Paolo RoccaTernium SA ADR
67
Jeong ChoiPOSCO Holdings
64
Wendell WeeksCorning Incorporated
64
Lawrence McRaeCorning Incorporated
65
Marcos SantosMarfrig Global Foods
N/A
Hak KimPOSCO Holdings
61
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ General Markets. It employs 161 people. Invuity (IVTY) is traded on NASDAQ Exchange in USA and employs 161 people.

Management Performance

Invuity Leadership Team

Elected by the shareholders, the Invuity's board of directors comprises two types of representatives: Invuity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invuity. The board's role is to monitor Invuity's management team and ensure that shareholders' interests are well served. Invuity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invuity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Invuity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invuity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Invuity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Invuity's short interest history, or implied volatility extrapolated from Invuity options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Invuity Stock

If you are still planning to invest in Invuity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invuity's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.